Feed/Investors/Luxin Venture Capital

Luxin Venture Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-04-09

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$110M

across 1 round

LATEST ROUND

Growth · $110M · 2026-04-09

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Oricell Oricell develops cell therapies specifically aimed at treating cancer patients, particularly through advanced CAR-T technology.	Growth Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$110M	2026-04-09	[ PART ]